These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28291692)

  • 1. Effects of varenicline on cognitive function in non-smokers with schizophrenia.
    Kozak K; Dermody SS; Rabin RA; Zack M; Barr MS; Tyndale RF; George TP
    Schizophr Res; 2018 Jul; 197():562-563. PubMed ID: 28291692
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia.
    Bridgman AC; Barr MS; Goodman MS; Zomorrodi R; Rajji T; Le Foll B; Chen R; Daskalakis ZJ; George TP
    Schizophr Res; 2016 Dec; 178(1-3):50-55. PubMed ID: 27613505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
    Smith RC; Amiaz R; Si TM; Maayan L; Jin H; Boules S; Sershen H; Li C; Ren J; Liu Y; Youseff M; Lajtha A; Guidotti A; Weiser M; Davis JM
    PLoS One; 2016; 11(1):e0143490. PubMed ID: 26730716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
    Roberts W; McKee SA
    Exp Clin Psychopharmacol; 2018 Feb; 26(1):49-57. PubMed ID: 29389170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys.
    Terry AV; Plagenhoef M; Callahan PM
    Psychopharmacology (Berl); 2016 Mar; 233(5):761-71. PubMed ID: 26612616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the nicotine receptor partial agonist varenicline moderate manic symptoms in heavy smokers with manic episodes?
    Chu CW; Kao CH; Chan CK
    Aust N Z J Psychiatry; 2018 Feb; 52(2):205. PubMed ID: 29226691
    [No Abstract]   [Full Text] [Related]  

  • 8. Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: The possible roles of inflammation, apoptosis, and synaptic factors.
    Seyedaghamiri F; Hosseini L; Kazmi S; Mahmoudi J; Shanehbandi D; Ebrahimi-Kalan A; Rahbarghazi R; Sadigh-Eteghad S; Farhoudi M
    Brain Res Bull; 2022 Apr; 181():36-45. PubMed ID: 35066097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis.
    Tanzer T; Shah S; Benson C; De Monte V; Gore-Jones V; Rossell SL; Dark F; Kisely S; Siskind D; Melo CD
    Psychopharmacology (Berl); 2020 Jan; 237(1):11-19. PubMed ID: 31792645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis.
    Falk DE; Castle IJ; Ryan M; Fertig J; Litten RZ
    J Addict Med; 2015; 9(4):296-303. PubMed ID: 26083958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline improves mood and cognition during smoking abstinence.
    Patterson F; Jepson C; Strasser AA; Loughead J; Perkins KA; Gur RC; Frey JM; Siegel S; Lerman C
    Biol Psychiatry; 2009 Jan; 65(2):144-9. PubMed ID: 18842256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotine nasal spray on cognitive function in schizophrenia.
    Smith RC; Warner-Cohen J; Matute M; Butler E; Kelly E; Vaidhyanathaswamy S; Khan A
    Neuropsychopharmacology; 2006 Mar; 31(3):637-43. PubMed ID: 16160711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine and cognition in schizotypal personality disorder.
    Kirrane RM; Mitropoulou V; Nunn M; Silverman J; Siever LJ
    Schizophr Res; 2001 Mar; 48(1):1-5. PubMed ID: 11278149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nicotine on electroencephalographic (EEG) and behavioural measures of visual working memory in non-smokers during a dual-task paradigm.
    Fisher DJ; Knobelsdorf A; Jaworska N; Daniels R; Knott VJ
    Pharmacol Biochem Behav; 2013 Jan; 103(3):494-500. PubMed ID: 23026057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders.
    Verplaetse TL; Pittman BP; Shi JM; Tetrault JM; Coppola S; McKee SA
    J Addict Med; 2016; 10(3):166-73. PubMed ID: 27159341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
    Evins AE; Hoeppner SS; Schoenfeld DA; Hoeppner BB; Cather C; Pachas GN; Cieslak KM; Maravic MC
    Schizophr Res; 2017 May; 183():124-129. PubMed ID: 27956009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    Jones C
    J Clin Psychopharmacol; 2018 Jun; 38(3):247-249. PubMed ID: 29505470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
    Grundey J; Amu R; Ambrus GG; Batsikadze G; Paulus W; Nitsche MA
    Psychopharmacology (Berl); 2015 Jul; 232(14):2491-501. PubMed ID: 25721074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
    Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
    Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.